SCHEMBL20429488

SCHEMBL20429488

CCc1ccccc1C(=O)OCc1ccc(C(CNC(=O)OC(C)(C)C)C(=O)Nc2ccc3cnccc3c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 19/20 0.60
ROCK1 Q13464 7/20 0.56
TNF P01375 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL173780 0.92 ROCK2 (0.63) ROCK2ROCK1
SCHEMBL22593380 0.90 ROCK2 (0.73) ROCK2ROCK1
SCHEMBL112454 0.87 ROCK2 (0.75) ROCK2ROCK1TNF
SCHEMBL174353 0.87 ROCK2 (0.75) ROCK2ROCK1TNF
SCHEMBL173486 0.87 ROCK2 (0.75) ROCK2ROCK1TNF
SCHEMBL162544 0.86 ROCK2 (0.67) ROCK2ROCK1TNF
SCHEMBL19750632 0.85 ROCK2 (0.61) ROCK2ROCK1
SCHEMBL29183948 0.84 ROCK2 (0.65) ROCK2ROCK1
SCHEMBL2776088 0.83 ROCK2 (0.67) ROCK2ROCK1
SCHEMBL30483630 0.83 ROCK2 (0.67) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354643-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2018-08-01 EP disclosed